Previous 10 | Next 10 |
Established partnership with Gilead Sciences to advance differentiated treatments for herpesviruses, HBV, HDV and beyond Now anticipate four development candidates from expanded pipeline in clinical development by the end of 2024 Named Anuj Gaggar, MD, PhD, as chief medical office...
2023-11-08 08:30:53 ET More on Assembly Biosciences Gilead and Assembly Bio ink deal for antiviral drugs Seeking Alpha’s Quant Rating on Assembly Biosciences Historical earnings data for Assembly Biosciences Financial information for Assembly Bioscienc...
-- Dr. Gaggar is an experienced industry executive with substantial infectious disease expertise and proven record of successfully leading early- and clinical-stage antiviral programs -- SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), ...
2023-10-19 10:00:13 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further...
2023-10-18 10:00:01 ET More on Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Stocks to watch in the Health Care sector as earnings close in BofA reports 10th consecutive week of equity inflows For further...
2023-10-17 12:22:32 ET DENVER, Colo., Oct. 17, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Assembly Biosciences Inc (NASDAQ: ASMB), Nkarta Inc (NASDAQ: NKTX), Tempest Therapeutics Inc (NASDAQ: ...
2023-10-17 10:05:35 ET DENVER, Colo., Oct. 17, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Assembly Biosciences Inc (NASDAQ: ASMB), WiSA Technologies Inc (NASDAQ: WISA), SciSparc Ltd (NASDAQ: SPRC), A...
2023-10-17 07:58:47 ET More on Assembly Biosciences Seeking Alpha’s Quant Rating on Assembly Biosciences Historical earnings data for Assembly Biosciences Financial information for Assembly Biosciences For further details see: Gilead and Assembly B...
––Partnership combines Gilead’s proven track record and mission to develop transformative therapeutics targeting serious viral diseases, with Assembly Bio’s expertise and focus on antiviral R&D to advance differentiated treatments for herpesviruses, HBV, HDV and be...
-- One poster and one oral presentation selected, with the poster highlighting new preclinical data from the Company’s interferon- α receptor agonist program -- SOUTH SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnol...
News, Short Squeeze, Breakout and More Instantly...
Assembly Biosciences Inc. Company Name:
ASMB Stock Symbol:
NASDAQ Market:
Assembly Biosciences Inc. Website:
2024-07-16 14:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– Data from both ABI-5366 and ABI-1179, novel long-acting helicase-primase inhibitor candidates for recurrent genital herpes, to be presented – – Poster presentation highlights key preclinical data from ABI-5366 supporting its entry into ongoing Phase 1a/b clinical ...
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the first participant has been dosed in the Phase 1b trial of ABI-4334, a nex...